Novacyt S.A.
Status: Publicly traded
Direct answer
Novacyt S.A. is publicly traded on LSE under the ticker NCYT.L.
Novacyt S.A., together with its associated entities, specializes in the research, production, contract design, and market launch of diagnostic solutions. These offerings are primarily developed for the detection of cancer and a range of infectious diseases. The company maintains an extensive international operational footprint, encompassing the United Kingdom, the broader European continent, the United States, the...
Can you invest in Novacyt S.A.?
Yes. Novacyt S.A. is publicly traded on LSE under the ticker NCYT.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Novacyt S.A.
Detailed equity research is provided by MarketSnap.